SE0700456L - Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur - Google Patents

Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur

Info

Publication number
SE0700456L
SE0700456L SE0700456A SE0700456A SE0700456L SE 0700456 L SE0700456 L SE 0700456L SE 0700456 A SE0700456 A SE 0700456A SE 0700456 A SE0700456 A SE 0700456A SE 0700456 L SE0700456 L SE 0700456L
Authority
SE
Sweden
Prior art keywords
titanium
injectable suspension
microstructure
present
particles
Prior art date
Application number
SE0700456A
Other languages
English (en)
Other versions
SE531318C2 (sv
Inventor
Lars Magnus Bjursten
Bengt Mjoeberg
Original Assignee
Tigran Technologies Ab Publ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39710285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0700456(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tigran Technologies Ab Publ filed Critical Tigran Technologies Ab Publ
Priority to SE0700456A priority Critical patent/SE531318C2/sv
Priority to BRPI0721338-7A priority patent/BRPI0721338A2/pt
Priority to PCT/SE2007/000985 priority patent/WO2008103082A1/en
Priority to KR1020097016369A priority patent/KR20090112685A/ko
Priority to CN2007800516511A priority patent/CN101631575B/zh
Priority to EP07835185.5A priority patent/EP2125059B1/en
Priority to JP2009550830A priority patent/JP2010519294A/ja
Priority to US12/527,831 priority patent/US20100104648A1/en
Publication of SE0700456L publication Critical patent/SE0700456L/sv
Publication of SE531318C2 publication Critical patent/SE531318C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/04—Metals or alloys
    • A61L27/06—Titanium or titanium alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0700456A 2007-02-22 2007-02-22 Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur SE531318C2 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0700456A SE531318C2 (sv) 2007-02-22 2007-02-22 Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur
BRPI0721338-7A BRPI0721338A2 (pt) 2007-02-22 2007-11-06 Tratamento de condições inflamatórias e/ou bacterianas com partículas de microestrutura
PCT/SE2007/000985 WO2008103082A1 (en) 2007-02-22 2007-11-06 Treatment of inflammatory and/or bacterial conditions with particles of microstructure
KR1020097016369A KR20090112685A (ko) 2007-02-22 2007-11-06 미소구조 입자를 이용한 염증성 및/또는 세균성 질환 치료 방법
CN2007800516511A CN101631575B (zh) 2007-02-22 2007-11-06 利用具有微结构的微粒的炎性和/或细菌性病症的处理
EP07835185.5A EP2125059B1 (en) 2007-02-22 2007-11-06 Treatment of inflammatory and/or bacterial conditions with particles of microstructure
JP2009550830A JP2010519294A (ja) 2007-02-22 2007-11-06 マイクロ構造の粒子による炎症症状および／または細菌性の症状の治療
US12/527,831 US20100104648A1 (en) 2007-02-22 2007-11-06 Treatment of inflammatory and/or bacterial conditions with particles of microstructure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0700456A SE531318C2 (sv) 2007-02-22 2007-02-22 Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur

Publications (2)

Publication Number Publication Date
SE0700456L true SE0700456L (sv) 2008-08-23
SE531318C2 SE531318C2 (sv) 2009-02-24

Family

ID=39710285

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0700456A SE531318C2 (sv) 2007-02-22 2007-02-22 Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur

Country Status (8)

Country Link
US (1) US20100104648A1 (sv)
EP (1) EP2125059B1 (sv)
JP (1) JP2010519294A (sv)
KR (1) KR20090112685A (sv)
CN (1) CN101631575B (sv)
BR (1) BRPI0721338A2 (sv)
SE (1) SE531318C2 (sv)
WO (1) WO2008103082A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143451A1 (en) * 2008-07-11 2010-01-13 Nobel Biocare Services AG Bone implant application
JP2013513648A (ja) * 2009-12-15 2013-04-22 ウニヴァーシテテット イ オスロ ＴｉＯ２のナノ粒子を含んでなる組成物
CN103153334B (zh) 2010-10-15 2016-11-16 斯特劳曼控股公司 包含pga的新的emd制剂
KR102302069B1 (ko) * 2010-11-10 2021-09-14 인리젠 장기 확대를 위한 주사가능 제제
CN104755112A (zh) * 2012-06-04 2015-07-01 米格拉塔英国有限公司 用于治疗创伤的医疗装置
EP2854868A4 (en) * 2012-06-04 2016-01-20 Migrata U K Ltd MEDICAL USE OF TITANIUM PARTICLES AND / OR TITANIUM OXIDE
CA2972949A1 (en) * 2015-01-06 2016-07-14 Osamu Yamada Medicinal composition, blood treatment device, cosmetic, food and drink using combustion synthesis material
CN104721176B (zh) * 2015-02-02 2018-07-10 中山大学 α-酮戊二酸在提高细菌对抗生素敏感性方面的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462638B (sv) * 1987-03-30 1990-08-06 Idea Ab Anordning foer fixering av en laangstraeckt protesdel
SE464911B (sv) * 1988-01-20 1991-07-01 Inst Applied Biotechnology Anti-inflammatoriskt medel, baserat paa reaktionsprodukten mellan h?712o?712 och titan, foerfarande foer dess framstaellning samt anvaendning daerav
US5006071A (en) * 1988-05-09 1991-04-09 Carter Dewey G Technique for the prevention of alveolar osteitis
SE468153B (sv) * 1990-10-08 1992-11-16 Astra Meditec Ab Saett foer ytbehandling av implantat av titan eller titanlegering
US5118667A (en) * 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
US5646187A (en) * 1992-05-20 1997-07-08 Ab Erik Vinnars Use of alpha-ketoglutarate
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
JP2795824B2 (ja) * 1995-05-12 1998-09-10 オオタ株式会社 チタン系インプラントの表面処理方法及び生体親和性チタン系インプラント
FR2758974B1 (fr) * 1997-02-03 1999-10-22 Onera (Off Nat Aerospatiale) Prothese metallique de soutien et/ou de remplacement tissulaire a porosite ouverte ainsi que son procede de fabrication
SE513481C2 (sv) * 1997-05-16 2000-09-18 Nobel Biocare Ab Implantatelement utfört av titan med en titanoxidyta modifierad med eloxidering
US20050031663A1 (en) * 1997-05-16 2005-02-10 Cecilia Larsson Implant element
BE1011899A6 (fr) * 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
SE515227C2 (sv) * 1999-04-28 2001-07-02 Bruce Medical Ab Kropp för åstadkommande av in- och tillväxt av benvävnad och/ eller bindväv och sätt för framställning av kroppen
WO2002100444A1 (en) * 2001-06-08 2002-12-19 Biosphere Medical Inc. Colloidal metal labelled microparticles, their production and use
DE10243132B4 (de) * 2002-09-17 2006-09-14 Biocer Entwicklungs Gmbh Antiinfektiöse, biokompatible Titanoxid-Beschichtungen für Implantate sowie Verfahren zu deren Herstellung
JP2005263659A (ja) * 2004-03-17 2005-09-29 Jitsukei Son 殺菌保護用乳液
US20060100138A1 (en) * 2004-11-10 2006-05-11 Olsen David R Implantable collagen compositions
JPWO2006126312A1 (ja) * 2005-05-25 2008-12-25 郁▲チョル▼ 金 光触媒を用いた医療用具
CN1305461C (zh) * 2005-08-09 2007-03-21 安徽大学 黄蜀葵无机纳米防晒乳液及制备方法
SE531319C2 (sv) * 2007-02-22 2009-02-24 Tigran Technologies Ab Publ Porös implantatgranul

Also Published As

Publication number Publication date
WO2008103082A1 (en) 2008-08-28
EP2125059B1 (en) 2014-08-13
EP2125059A4 (en) 2013-05-08
JP2010519294A (ja) 2010-06-03
CN101631575A (zh) 2010-01-20
SE531318C2 (sv) 2009-02-24
US20100104648A1 (en) 2010-04-29
CN101631575B (zh) 2013-09-18
BRPI0721338A2 (pt) 2014-02-25
EP2125059A1 (en) 2009-12-02
KR20090112685A (ko) 2009-10-28

Similar Documents

Publication Publication Date Title
SE0700456L (sv) Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
EA201100765A1 (ru) Наночастицы длительной циркуляции для замедленного высвобождения терапевтических средств
NL300874I2 (nl) Elosulfase alfa
MY161495A (en) Virus like particle compositions and methods of use
WO2008073922A3 (en) Functions and targets of let-7 micro rnas
WO2010083239A3 (en) Therapeutic modulation of vaginal epithelium boundary lubrication
MY155961A (en) Chemical compounds 251
SG10201803862UA (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
EP2175834B8 (en) Glp-1-fc fusion protein formulation
EA201200793A1 (ru) Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
EP1880719A3 (en) Composition for prophylaxis or treatment of urinary system infection and method thereof
EA201170349A1 (ru) Модуляторы mif
EA200701195A1 (ru) Содержащие цефалоспорин композиции с наночастицами и с контролируемым высвобождением
WO2011035335A3 (en) Stabilized liquid and lyophilized adamts13 formulations
HK1126390A1 (en) Use of citrulline in the manufacture of a medicament for the correction of arginine deficiency in septic patients
WO2008151749A3 (de) Aktivierbare diagnostische und therapeutische verbindung
WO2010088450A3 (en) Arylamide derivatives useful in the treatment of diseases associated with serca activity
WO2011075606A3 (en) Hyperglycosylated polypeptide variants and methods of use
WO2014016816A3 (pt) Malha polímerica com permeabilidade seletiva, para a regeneraçâo/reparação de tecidos
DE602007011975D1 (de) Thiadiazolderivate zur behandlung neurodegenerativer krankheiten
EP2889034A3 (en) Compositions and methods of treatment comprising ceftaroline
WO2007130501A3 (en) Combination therapy for treatment of cancer
WO2011011706A3 (en) Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents
WO2010042633A3 (en) Naringenin complexes and methods of use thereof

Legal Events

Date Code Title Description
NUG Patent has lapsed
NAV Patent application has lapsed